Xenon Pharmaceuticals Inc
Company Overview
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics to improve the lives of patients with neurological disorders. The company's primary focus is on developing novel treatments for epilepsy and other central nervous system disorders.
Their lead product candidate, XEN496 (ezogabine), is being developed for the treatment of KCNQ2 developmental and epileptic encephalopathy (KCNQ2-DEE). They are also developing XEN1101, a differentiated Kv7 potassium channel opener for the treatment of epilepsy and potentially other neurological disorders.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Xenon Pharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.